RE:RE:Supreme Cannabis Upgraded by Multiple Analysts!
Problem is not so much 'manipulation' but this company was legit starring down insolvency in mid/late 2020. That can not be quantified easily. This company was all but written off as far as institutional investment sentiment goes imho. Me I consume cannabis and am acutely aware of Supremes product quality and consistency vs the market as a whole. I stuck because of that. Major investors though want results. They are coming. One quarter with a questional positive ebitda followed up by a second well received quarter and legit postive ebitda is where we are at. The retail market share gains will continue. The big dogs, if you will, are waiting for a proper steak to chew on. Next ER should help if not do it. I believe they will look past Israel shipment and see what they are waiting for; retail growth. This company now needs to start producing positive EPS. That will dictate our SP moving forward which I am all for as that is proper not pure speculation. 4-5$? Not as is but 1.50-2.00 with an annual projected .15 EPS is fair. After that who knows. A .15 annual EPS is small but manageable but it is what most LPs lack so who knows?